Advertisement

Infection

, Volume 21, Issue 1, pp 49–53 | Cite as

Timing, dosing and duration of antimicrobial prophylaxis in urology: A study in guinea pigs with special reference to high-risk conditions

  • T. C. Gasser
  • P. O. Madsen
Originalia

Summary

A study in guinea pigs was performed to investigate the importance of timing, dosage and duration of antimicrobial prophylaxis in urologic surgery. To simulate high-risk conditions, in one group a foreign body was implanted subcutaneously. The prostate and one kidney were cauterized and bacteremia was induced by intravenous injection of anEscherichia coli suspension. Various ciprofloxacin regimens were tested. The results indicate that antimicrobial prophylaxis is beneficial only if administered before or shortly after surgery. Full therapeutic dosage may not be necessary for prophylactic efficacy. Single-dose prophylaxis was as effective as multiple doses. Foreign body infection could be prevented by single-dose prophylaxis.

Keywords

Foreign Body Therapeutic Dosage Multiple Dose Antimicrobial Prophylaxis Prophylactic Efficacy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Zeitpunkt, Dosierung und Dauer antimikrobieller Prophylaxe in der Urologie: Studien am Meerschweinchen zu Hochrisiko-Eingriffen

Zusammenfassung

Um die Bedeutung von Zeitpunkt, Dosierung, und Dauer antimikrobieller Prophylaxe in der urologischen Chirurgie zu untersuchen, wurde eine experimentelle Studie an Meerschweinchen durchgeführt. Einer Gruppe von Tieren wurde vier Wochen vor den Experimenten ein subkutaner Fremdkörper implantiert. Sie diente als Riskikogruppe. Die Prostata und eine Niere wurden elektrokoaguliert. Durch intravenöse Injektion einerEscherichia coli-Suspension wurde eine Bakteriämie erzeugt. Ciprofloxacin wurde zu verschiedenen Zeitpunkten, in verschiedenen Dosierungen und unterschiedlich lange verabreicht. Antimikrobielle Prophylaxe war wirksam, wenn sie kurz vor oder nach den Bakterien verabreicht wurde. Ein Teil der normalen therapeutischen Dosis scheint für eine wirkungsvolle Prophylaxe auszureichen. Die Einmaldosierung war ebenso wirksam wie die Mehrfachdosierung. Die Fremdkörperinfektion konnte durch eine einzelne Dosis zuverlässig verhindert werden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Burke, J. F. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 50 (1961) 161–168.Google Scholar
  2. 2.
    Kunin, C. M., Johansen, K. S., Worning, A. M., Daschner, F. D. Report of a symposium on use and abuse of antibiotics worldwide. Rev. Infect. Dis. 12 (1990) 12–19.Google Scholar
  3. 3.
    Zimmerli, W., Zak, O., Vosbeck, K. Experimental hematogenous infection of subcutaneously implanted foreign bodies. Scand. J. Infect. Dis. 17 (1985) 303–310.Google Scholar
  4. 4.
    Sullivan, N. M., Sutter, V. L., Finegold, S. M. Practical aerobic membrane filtration blood culture technique: development of procedure. J. Clin. Microbiol. 1 (1975) 30–36.Google Scholar
  5. 5.
    Nielsen, O. S., Madsen, P. O. Importance and timing of prophylactic antibiotics in urology with a special reference to growth and kill rates ofE. coli in genitourinary organs. J. Urol. 123 (1982) 608–614.Google Scholar
  6. 6.
    Larsen, E. H., Gasser, T. C., Madsen, P. O. Antimicrobial prophylaxis in urologic surgery. Urol. Clin. N. Am. 13 (1986) 591–604.Google Scholar
  7. 7.
    Murphy, D. M., Stassen, L., Carr, M. E., Gillespie, W. A., Cafferkey, M. T., Falkiner, F. R. Bacteraemia during prostatectomy and other transurethral operations: influence of timing of antibiotic administration. J. Clin. Pathol. 37 (1984) 673–676.Google Scholar
  8. 8.
    Robinson, M. R. G., Arudpragasam, S. T., Sahgal, S. M., Cross, R. J., Akdas, A., Fittal, B., Sibbald, R. Bacteraemia resulting from prostatic surgery: the source of bacteria. Br. J. Urol. 54 (1982) 542–546.Google Scholar
  9. 9.
    Hellsten, S., Forsgren, A., Björk, T., Grabe, M. Use of ciprofloxacin in patients undergoing transurethral prostatic surgery. Scand J. Infect. Dis. 60 (Suppl.) (1989) 104–107.Google Scholar
  10. 10.
    Nielsen, K. T., Madsen, P. O. Quinolones in urology. Urol. Res. 17 (1989) 117–124.Google Scholar
  11. 11.
    Gasser, T. C., Ebert, S. C., Graversen, P. H., Madsen, P. O. Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function. Antimicrob. Agents Chemother. 31 (1987) 709–712.Google Scholar
  12. 12.
    Hargreave, T. B., Gould, J. C., Kinninmonth, A. W. G., Jeffrey, R. R., Varma, J. S., Macintyre, C. C. A., Elton, R. A., Chisholm, G. D. A randomized trial of 48 hours of prophylactic cefotaxime versus single dose in transurethral prostatic surgery. J. Antimicrob. Chemother. 14 (Suppl. B) (1984) 263–269.Google Scholar
  13. 13.
    Grabe, M., Forsgren, A., Björk, T., Hellsten, S. Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery. Eur. J. Clin. Microbiol. 6 (1987) 11–17.Google Scholar
  14. 14.
    Shearman, C. P., Silverman, S. H., Johnson, M., Young, C. H., Farrar, D. J., Keighley, M. R. B., Burdon, D. W. Single dose, oral antibiotic cover for transurethral prostatectomy. Br. J. Urol. 62 (1988) 434–438.Google Scholar
  15. 15.
    Widmer, A. F., Wiestner, A., Frei, R., Zimmerli, W. Killing of nongrowing and adherentEscherichia coli determines drug efficacy in device-related infections. Antimicrob. Agents Chemother. 35 (1991) 741–746.Google Scholar
  16. 16.
    Hooper, D. C., Wolfson, J. S. Fluoroquinolone antimicrobial agents. N. Engl. J. Med. 324 (1991) 384–394.Google Scholar
  17. 17.
    Gasser, T. C., Graversen, P. H., Madsen, P. O. Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids. Antimicrob. Agents Chemother. 31 (1987) 1010–1013.Google Scholar
  18. 18.
    Nickel, J. C., Heaton, J., Morales, A., Costerton, J. W. Bacterial biofilm in persistent penile prosthesis-associated infection. J. Urol. 135 (1986) 586–588.Google Scholar

Copyright information

© MMV Medizin Verlag GmbH München 1993

Authors and Affiliations

  • T. C. Gasser
    • 1
  • P. O. Madsen
    • 2
  1. 1.Urologische Klinik, Kantonsspital BaselBaselSwitzerland
  2. 2.VA HospitalMadisonUSA

Personalised recommendations